CJ Bioscience Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 90
Employees
  • Stock Symbol
  • 311690
Stock Symbol
  • Share Price
  • $31.19
  • (As of Monday Closing)

CJ Bioscience General Information

Description

CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.

Contact Information

Website
www.cjbioscience.com
Formerly Known As
ChunLab
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Stock Exchange
KRX
Primary Office
  • 7th Floor, Grand Central Building B
  • Sejong-daero, Jung-gu
  • Seoul
  • South Korea
+82 00-0000-0000

CJ Bioscience Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CJ Bioscience Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$31.19 $33.07 $24.35 - $63.37 $183M 5.86M 33.8K -$3.38

CJ Bioscience Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 136,100 179,462 97,439
Revenue 4,941 4,499 4,102 3,570
EBITDA (7,837) (5,443) (3,237) (2,605)
Net Income (13,220) (7,422) (3,727) (2,852)
Total Assets 54,844 67,248 29,129 11,477
Total Debt 33,772 32,785 637 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CJ Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CJ Bioscience‘s full profile, request access.

Request a free trial

CJ Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and s
Biotechnology
Seoul, South Korea
90 As of 2021
000.00
0000 0000-00-00
000000000 000.00

0000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
0000000000000
South Plainfield, NJ
000 As of 0000
0000 0000-00-00
000000&0

00000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000000000000
Woburn, MA
0 As of 0000
0000
00.00 0000-00-00
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CJ Bioscience Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genewiz Formerly VC-backed South Plainfield, NJ 000 000000&0
00000 Corporation Woburn, MA 0 0000 00000000 0000
0000000 0000000000 Venture Capital-Backed Brisbane, CA 000 00000 00000 00000 00000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
000000 Formerly VC-backed Vista, CA 000 00000 00000000 00000
You’re viewing 5 of 23 competitors. Get the full list »

CJ Bioscience Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

CJ Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020247154-A1 Faecalibacterium sp. microbe and anticancer composition comprising same Pending 28-Mar-2019 00000000
EP-3848936-A1 Method for identifying and classifying sample microorganisms Pending 05-Sep-2018 000000000
US-20210202040-A1 Method for identifying and classifying sample microorganisms Pending 05-Sep-2018 000000000
US-20200234792-A1 Method for obtaining microorganism information using tetra-nucleotide frequency Abandoned 22-Feb-2017 000000000
EP-3511847-A1 Method for obtaining ribosomal rna (rrna) sequence information and method for identifying microorganism using rrna Withdrawn 27-Dec-2016 G16B30/10
To view CJ Bioscience’s complete patent history, request access »

CJ Bioscience Executive Team (3)

Name Title Board Seat Contact Info
Chun Jong-sik Ph.D Founder & Chief Executive Officer
Hyejin Hwang Chief Strategy Officer
You’re viewing 2 of 3 executive team members. Get the full list »

CJ Bioscience Board Members (1)

Name Representing Role Since
Yu-Seok Oh CJ Bioscience Chairman 000 0000
To view CJ Bioscience’s complete board members history, request access »

CJ Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CJ Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CJ Bioscience‘s full profile, request access.

Request a free trial